Uploaded image for project: 'eCQM Issue Tracker'
  1. eCQM Issue Tracker
  2. CQM-6139

VTE 1 - Why does Oral Factor Xa Inhibitor medication require Diagnosis of AFib/prior diagnosis of VTE or hip or knee replacement?

XMLWordPrintable

    • Icon: EC eCQMs - Eligible Clinicians EC eCQMs - Eligible Clinicians
    • Resolution: Answered
    • Icon: Moderate Moderate
    • None
    • None
    • Hide
      ​​Thank you for your inquiry on CMS108, Venous Thromboembolism Prophylaxis.

      Oral Factor Xa Inhibitor medication requires Diagnosis of AFib/prior diagnosis of VTE or hip or knee replacement in order to pass the numerator, as it follows FDA guidance. We continuously monitor FDA approved indications for medications included in the value set, e.g., apixaban.
      Show
      ​​Thank you for your inquiry on CMS108, Venous Thromboembolism Prophylaxis. Oral Factor Xa Inhibitor medication requires Diagnosis of AFib/prior diagnosis of VTE or hip or knee replacement in order to pass the numerator, as it follows FDA guidance. We continuously monitor FDA approved indications for medications included in the value set, e.g., apixaban.
    • CMS0108v11

      For this section of the numerator, why does an Oral Factor Xa inhibitor medication need a dx of AFib or VTE or a hip or knee replacement? Why wouldn't just an Oral Factor Xa inhibitor medication administration lead to a Met status without those diagnoses or procedures?

       

        1. image-2023-06-05-10-20-25-578.png
          image-2023-06-05-10-20-25-578.png
          11 kB

            JLeflore Joelencia Leflore
            JPeeler Jay Peeler
            Votes:
            0 Vote for this issue
            Watchers:
            3 Start watching this issue

              Created:
              Updated:
              Resolved:
              Solution Posted On: